Phenylketonuria (PKU) Emerging Therapy Assessment

Phenylketonuria (PKU) Emerging Therapy Assessment

Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Synlogic, Censa Pharmaceuticals, Codexis, Homology Medicines, etc., are developing therapies for the treatment of patients with Phenylketonuria (PKU).

Source: www.delveinsight.com/report-store/phenylketonuria-pku-market

 

 

Done